Sort of expecting some update this week leading into these investor presentations, seems it would be beneficial for them to Ann prior than be bombarded with questions at the event about how much longer for ROW....
There is a lot to talk about and the company has exciting next few months, however ROW deal is becoming something that needs to be finalised.
Understanding the complexities of the ROW deal that have been well noted on HC, I think its fair for us to know now what the companies intentions are by finalising or otherwise.
For me it adds minimum $7 straight to the share price, there is no doubt its holding share price back as its a market we can't sell in yet US sales start this week. It will take some time for ROW to launch also and the longer we don't know the longer we are not in that market.
Even if they announced EU deal now and other regions to follow.
The share price has been well controlled for some time leading into FDA and now post FDA at the $13 range so perhaps something in play already....
Pending ROW deal??, page-228
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.27 |
Change
0.650(3.15%) |
Mkt cap ! $2.718B | |||
| Open | High | Low | Value | Volume |
| $20.84 | $21.56 | $20.76 | $7.760M | 364.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1378 | $21.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.29 | 218 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |